Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06922084 · ClinicalTrials.gov registry record · Phase 4
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
A Phase 4 study of Cataract, sponsored by Berkeley Eye Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 320
- Enrollment target
- 2
- Study locations
NCT06922084 is a Phase 4 study of Cataract that is actively recruiting participants, run by Berkeley Eye Center. The registered enrollment target is 320 participants, above the 225-participant average among 83 other Cataract trials with a reported enrollment target (42% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06922084, a Phase 4 study of Cataract, is actively recruiting participants, sponsored by Berkeley Eye Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 320 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, randomized, multicenter, multi-arm, subject and vision-assessor-masked, two stage study with Stage 1 as a three-arm initial enrollment period, followed by Stage 2 as a head-to-head study refined based on the Stage 1 data.
Conditions Studied
Interventions
- DEVICE Clareon PanOptix
- DRUG Clareon PanOptix PRO
- DRUG Mix-and-Match PanOptix/Vivity
Study Locations (2)
Pennsylvania
- Shafer Vision Institute - Plymouth Meeting
Texas
- Berkeley Eye Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2025-03-17 |
| Est. Completion | 2026-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06922084
The ClinicalTrials.gov registry entry for NCT06922084 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 225-participant average among 83 other Cataract trials with a reported enrollment target (42% higher). The listed sponsor is Berkeley Eye Center, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 3 interventions - of which Clareon PanOptix is the first listed.
NCT06922084 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT06922084 about?
NCT06922084 is a clinical study titled "A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects". Prospective, randomized, multicenter, multi-arm, subject and vision-assessor-masked, two stage study with Stage 1 as a three-arm initial enrollment period, followed by Stage 2 as a head-to-head study refined based on the Stage 1 data.
What is the current status of trial NCT06922084?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 320 participants. The study started on 2025-03-17. Estimated completion is 2026-04.
What conditions does trial NCT06922084 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT06922084?
The interventions under investigation include: Clareon PanOptix (DEVICE), Clareon PanOptix PRO (DRUG), Mix-and-Match PanOptix/Vivity (DRUG).
Who is sponsoring clinical trial NCT06922084?
This trial is sponsored by Berkeley Eye Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06922084 being conducted?
This trial has 2 study locations across Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
-
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.